scholarly journals A Decade of Fighting Invasive Meningococcal Disease: A Narrative Review of Clinical and Real-World Experience with the MenACWY-CRM Conjugate Vaccine

2021 ◽  
Author(s):  
Yara Ruiz Garcia ◽  
Véronique Abitbol ◽  
Michele Pellegrini ◽  
Rafik Bekkat-Berkani ◽  
Lamine Soumahoro
Keyword(s):  
Conjugate Vaccine ◽  
Real World ◽  
Meningococcal Disease ◽  
Narrative Review ◽  
Invasive Meningococcal Disease

scholarly journals Epidemiology of invasive meningococcal disease in Germany, 2002–2010, and impact of vaccination with meningococcal C conjugate vaccine

2013 ◽  
Vol 66 (1) ◽  
pp. 48-56 ◽  
Author(s):  
Wiebke Hellenbrand ◽  
Johannes Elias ◽  
Ole Wichmann ◽  
Manuel Dehnert ◽  
Matthias Frosch ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Meningococcal Disease ◽  
Invasive Meningococcal Disease

Invasive Meningococcal Disease in Africa’s Meningitis Belt: More Than Just Meningitis?

2019 ◽  
Vol 220 (Supplement_4) ◽  
pp. S263-S265 ◽  
Author(s):  
Heather E Reese ◽  
Olivier Ronveaux ◽  
Jason M Mwenda ◽  
Andre Bita ◽  
Adam L Cohen ◽  
...  
Keyword(s):  
Conjugate Vaccine ◽  
Meningococcal Disease ◽  
Disease Surveillance ◽  
Clinical Presentation ◽  
Case Fatality ◽  
Clinical Syndrome ◽  
Invasive Meningococcal Disease ◽  
World Health ◽  
Case Fatality Ratio ◽  
Meningitis Belt

Abstract Since the progressive introduction of the meningococcal serogroup A conjugate vaccine within Africa’s meningitis belt beginning in 2010, the burden of meningitis due to Neisseria meningitidis serogroup A (NmA) has substantially decreased. Non-A serogroups C/W/X are now the most prevalent. Surveillance within the belt has historically focused on the clinical syndrome of meningitis, the classic presentation for NmA, and may not adequately capture other presentations of invasive meningococcal disease (IMD). The clinical presentation of infection due to serogroups C/W/X includes nonmeningeal IMD, and there is a higher case-fatality ratio associated with these non-A serogroups; however, data on the nonmeningeal IMD burden within the belt are scarce. Expanding surveillance to capture all cases of IMD, in accordance with the World Health Organization’s updated vaccine-preventable disease surveillance standards and in preparation for the anticipated introduction of a multivalent meningococcal conjugate vaccine within Africa’s meningitis belt, will enhance meningococcal disease prevention across the belt.

scholarly journals PIN152 ECONOMIC IMPACT OF SEQUELAE RELATED TO INVASIVE MENINGOCOCCAL DISEASE IN A FRENCH REAL-WORLD SETTING

2019 ◽  
Vol 22 ◽  
pp. S663
Author(s):  
S. Fievez ◽  
M. Tin Tin Htar ◽  
J. Weller ◽  
M. Goguillot ◽  
S. Bénard ◽  
...  
Keyword(s):  
Economic Impact ◽  
Real World ◽  
Meningococcal Disease ◽  
Invasive Meningococcal Disease ◽  
Real World Setting

scholarly journals The Epidemiology of Invasive Meningococcal Disease in the Kingdom of Saudi Arabia: A Narrative Review with Updated Analysis

2021 ◽  
Author(s):  
Selim Badur ◽  
Mona A. Al Dabbagh ◽  
Atef M. Shibl ◽  
Fayssal M. Farahat ◽  
Serdar Öztürk ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Meningococcal Disease ◽  
Narrative Review ◽  
Invasive Meningococcal Disease ◽  
Kingdom Of Saudi Arabia

scholarly journals Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy

Vaccine ◽  
2018 ◽  
Vol 36 (29) ◽  
pp. 4222-4227 ◽  
Author(s):  
Patrizio Pezzotti ◽  
Alessandro Miglietta ◽  
Arianna Neri ◽  
Cecilia Fazio ◽  
Paola Vacca ◽  
...  
Keyword(s):  
Neisseria Meningitidis ◽  
Conjugate Vaccine ◽  
Meningococcal Disease ◽  
Vaccine Effectiveness ◽  
Invasive Meningococcal Disease
Sign in / Sign up

Export Citation Format

Share Document